ECP 2022 Final Programme

177 ECP 2022 Basel © 2022 Bristol-Myers Squibb Company. ONC-CH-2200024 June/22 Sunday, 4 September 2022  |  13:00–14:30 CEST Onco-Pathology Forum: A Multidisciplinary Approach to Biomarker Diagnostics and Care ECP 2022 Industry Satellite Symposium 13:00–13:15 Welcome and Introduction Professor Reinhard Büttner - Meeting Chair University of Cologne Cologne, Germany 13:15–13:25 Key Results of Immunotherapy Trials in Advanced Upper GI Tract Cancers: What Pathologists Need to Know FromGI Oncology for Personalized Medicine Professor Markus Möhler Johannes Gutenberg-University Mainz Mainz, Germany 13:25–13:35 Are We Ready to Move Into an Age of Biomarker-Driven Neoadjuvant Therapy in Advanced Upper GI Tract Cancers? What GI Oncologists Need to Know From a Pathology Report Professor Thomas Zander University of Cologne Cologne, Germany 13:35–13:45 The GI Pathologist Perspective: Diagnostic Biomarkers for Advanced Upper GI Tract Cancers Professor Alexander Quaas University of Cologne Cologne, Germany 13:45–13:55 Biomarker-Driven Therapies in Bladder Cancer: What Uro-oncologists Need to Know From a Pathology Report Professor Juan Palou Redorta Autonomous University of Barcelona Barcelona, Spain 13:55–14:05 Biomarker-Driven Therapies Beyond Immuno-Oncology: What Oncologists Need to Know From a Pathology Report Professor Aristotelis Bamias National and Kapodistrian University of Athens Athens, Greece 14:05–14:15 The Uropathologist Perspective: Diagnostic Biomarkers for Bladder Cancer Professor Eva Compérat Medical University of Vienna Vienna, Austria 14:15–14:30 Audience Q&A to Follow Presentations This Industry-Sponsored Symposium Is a Medical Education Activity That Is Organized and Funded by the Medical Department of Bristol Myers Squibb.